A 52-year-old woman with a 2-month history of progressive dyspnea, hemoptysis, and constitutional symptoms is found to have pulmonary infiltrates on chest X-ray and a serum creatinine of 2.1 mg/dL. Urinalysis reveals dysmorphic RBCs and RBC casts. ANCA serology shows positive c-ANCA with anti-PR3 antibodies. Which investigation is most appropriate to confirm the diagnosis and assess disease extent?

Explanation

## Diagnosis of ANCA-Associated Vasculitis (Granulomatosis with Polyangiitis) **Key Point:** Renal biopsy with light microscopy (LM), immunofluorescence (IF), and electron microscopy (EM) is the gold standard for confirming ANCA-associated vasculitis (AAV) and assessing the extent of glomerulonephritis, which guides treatment intensity. ### Clinical Presentation Recognition The patient presents with features consistent with **Granulomatosis with Polyangiitis (GPA)**: - Pulmonary involvement (dyspnea, hemoptysis, infiltrates) - Renal involvement (dysmorphic RBCs, RBC casts, elevated creatinine) - Constitutional symptoms (fever, malaise) - **Positive c-ANCA with anti-PR3 antibodies** (highly specific for GPA) ### Why Renal Biopsy is the Confirmatory Investigation | Investigation | Role in AAV Diagnosis | Specificity | Utility | |---|---|---|---| | **ANCA serology** | Supportive, not diagnostic | High for AAV type | Guides differential, but not sufficient alone | | **Renal biopsy (LM/IF/EM)** | **Gold standard for confirmation** | Diagnostic (ANCA-negative pauci-immune GN) | Confirms diagnosis + assesses severity | | **Lung biopsy** | Diagnostic if granulomas present | High but invasive | Reserved for atypical presentations | | **HRCT chest** | Assesses extent of pulmonary disease | Moderate (non-specific infiltrates) | Supportive, not diagnostic | **High-Yield:** ANCA-associated vasculitis is characterized by **pauci-immune glomerulonephritis** on renal biopsy—minimal or absent immunoglobulin deposition on IF, distinguishing it from immune complex vasculitides (e.g., IgA vasculitis, lupus). ### Renal Biopsy Findings in GPA 1. **Light Microscopy:** Segmental necrotizing glomerulonephritis, crescent formation (cellular, fibrocellular, or fibrous) 2. **Immunofluorescence:** **Pauci-immune pattern** (absent or minimal IgG, IgA, IgM, C3) 3. **Electron Microscopy:** Absence of electron-dense deposits (confirms pauci-immune pattern) **Clinical Pearl:** Although ANCA serology is highly supportive (c-ANCA/PR3 is ~90% specific for GPA), renal biopsy is still required to confirm the diagnosis and assess the degree of glomerular damage, which determines the intensity of immunosuppressive therapy (e.g., induction therapy with cyclophosphamide or rituximab for severe disease). **Mnemonic:** **PAUCI-ANCA** = **Pauci-immune** glomerulonephritis confirmed by **Renal biopsy** in **ANCA-associated** vasculitis. ```mermaid flowchart TD A[Suspected ANCA-associated vasculitis]:::outcome --> B[ANCA serology: c-ANCA/p-ANCA?]:::decision B -->|Positive c-ANCA/PR3| C[GPA likely]:::outcome B -->|Positive p-ANCA/MPO| D[MPA or EGPA likely]:::outcome C --> E[Renal biopsy for confirmation]:::action D --> E E --> F{Pauci-immune GN?}:::decision F -->|Yes| G[ANCA-associated vasculitis confirmed]:::outcome F -->|No| H[Consider alternative diagnosis]:::outcome G --> I[Assess crescent type & severity]:::action I --> J[Guide induction therapy intensity]:::action ``` [cite:Harrison 21e Ch 319; Robbins 10e Ch 11]